The Global Health Body Issues Concern Over Acute Shortage of Obesity Medications
Under 10% of people who could benefit from weight-loss injections such as Wegovy are able to get them, states the World Health Organization as it issues its initial guidance on the medications.
Given over a billion individuals worldwide currently classified as obese, it is urging broader and more equitable availability to this class of drugs.
Per projections, over two billion will be living with obesity by 2030 without intervention.
"The new guidance affirms that excess weight is a lifelong illness that can be managed with comprehensive and lifelong support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are key barriers to universal access to the jabs that can aid individuals in losing substantial weight, says the body.
Skinny Jab Scarcity
Even under the present most favorable scenario, the manufacturing of these medications could only cover about 100 million people – less than 10% of those who need them, as stated by the WHO.
The guideline urges countries and companies to widen availability, via measures like licensing agreements.
The intellectual property rights on the active ingredient – the core ingredient of the drug Wegovy – is scheduled to end in several countries in 2026.
The Way Obesity Injections Operate
GLP-1 drugs imitate a natural hormone to slow digestion, curb appetite and enhance feelings of fullness so individuals reduce food intake.
Patients commonly see weight reduction in the initial weeks of beginning the once-weekly jabs.
Studies suggests users may regain a significant portion a year later of stopping the medication, because their typical food cravings resume.
To be overweight or obese elevates your risk for experiencing medical conditions, including type 2 diabetes, heart disease, stroke, and certain malignancies.
Excess weight impacts people in all nations and was responsible for millions of fatalities worldwide in 2024, per the WHO.
